4 resultados
This application was filed under 35 U.S.C. 371, and is the U.S. National Stage of PCT/JP00/08517, filed Dec. 1, 2000.
TECHNICAL FIELD
The present invention relates to triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient.
More particularly,
TECHNICAL FIELD
The present invention relates to triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising the same, as an active ingredients.
More particularly, it relates to triazaspiro[5.5]undecane derivatives of the formula (I)
##STR00002## (wherein all the symbols have the
This application was filed under 35 U.S.C. 371, and is the U.S. National Stage of PCT/JP02/02554, filed 18 Mar. 2002.
TECHNICAL FIELD
The present invention relates to triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising the same, as an active ingredients.
More
This application is a 371 of PCT/JP03/11835 filed Sep. 17, 2003 which claims priority to JAPAN 2002-272079 filed Sep. 18, 2002.
TECHNICAL FIELD
The present invention relates to crystals of (3R)-1-butyl-2,5-dioxo-3-((1R)-1-hydroxy-1-cyclohexylmethyl)-9-(4-(4-carb-